Open access
Open access
Powered by Google Translator Translator

[Abstract Only] Randomized Trial: Olanzapine Plus Standard Antiemetic Therapy for the Prevention of Chemotherapy-induced Nausea and Vomiting

8 Jan, 2020 | 22:12h | UTC

Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial – The Lancet Oncology (link to abstract – $ for full-text)


Related Commentary on Twitter


Stay Updated in Your Specialty

No spam, just news.